Hyperinsulinism and sex hormones in young adult African Americans

Metabolism: Clinical and Experimental

Volumn 48, Issue 1, 1999, Pages 107-112

  Falkner, Bonita ^a   Sherif, Katherine ^a   Sumner, Anne ^a   Kushner, Harvey ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY RISK; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; TESTOSTERONE BLOOD LEVEL;

EID: 0032923833     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90018-5     Document Type: Article

References (38)

1. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
2. Center for Health Statistics: Health, United States, 1988. Department of Health and Human Services, Public Health Service Publication No. 89-1232. Washington, DC, US Government Printing Office, March 1989
3. Kannel WB, Hjortland MC, McNamara PM, et al: Menopause and risk of cardiovascular disease. The Framingham Study. Ann Intern Med 85:447-452, 1976
4. Haffner SM, Valdez RA: Endogenous sex hormones: Impact on lipids, lipoproteins, and insulin. Am J Med 98:40S-47S, 1995 (suppl)
5. Haffner SM, Katz MS, Stern MP, et al: Association of decreased sex hormone binding globulin and cardiovascular risk factors. Arteriosclerosis 9:136-143, 1989
6. Haffner SM, Dunn JF, Katz MS: Relationship of sex hormone-binding globulin to lipids, lipoproteins, glucose and insulin concentrations in postmenopausal women. Metabolism 41:278-284, 1992
7. Lindstedt G, Lundberg PA, Lapidus L, et al: Low sex-hormone binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes 40:123-128, 1991
8. Berger GMB, Naidoo J, Gounden N, et al: Marked hyperinsulinaemia in postmenopausal, healthy Indian (Asian) women. Diabet Med 12:788-795, 1995
9. Preziosi P, Barrett-Connor E, Papoz L, et al: Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: The Telecom Study. J Clin Endocrinol Metab 76:283-287, 1993
10. Haffner SM, Valdez RA, Morales PA, et al: Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men. J Clin Endocrinol Metab 77:56-60, 1993
11. Burghen GA, Givens JR, Kitabchi AE: Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 50:113-116, 1980
12. Dunaif A: Insulin resistance and ovarian dysfunction. Endocrinologist 2:248-260, 1992
13. Velazquez EM, Mendoza S, Hamer T, et al: Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating formal menses and pregnancy. Metabolism 43:647-654, 1994
14. Nestler JE, Powers LP, Matt DW, et al: A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 72:83-89, 1991
15. Dunaif A, Scott D, Finegood D, et al: The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 81:3299-3306, 1996
16. Kiddy DS, Hamilton-Fairley D, Seppala M, et al: Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: Correlation with serum insulin and insulin-like growth factor-I. Clin Endocrinol (Oxf) 31:757-763, 1989
17. Kiddy DS, Hamilton-Fairley D, Bush A, et al: Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 36:105-111, 1992
18. Wormsley J, Durnin JV: A comparison of the skinfold method with extent of overweight and various height-weight relationships in assessment of obesity. Br J Nutr 38:271-284, 1997
19. -. Clin Chem 30:839-842, 1984
20. Friedewald WT, Levy RI, Frederickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
21. Kumanyika SK: Special issues regarding obesity in minority populations. II. Ann Intern Med 119:650-654, 1993
22. Manolio TA, Savage PJ, Burke GL, et al: Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA Study. Arteriosclerosis 10:430-436, 1990
23. DeFronzo RA, Ferrannini E: Insulin resistance: A multifaceted syndrome responsible for NIDDM, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
24. Falkner B, Kushner H, Tulenko T, et al: Insulin sensitivity, lipids, and blood pressure in young African Americans. Arterioscler Thromb Vasc Biol 15:1798-1804, 1995
25. Sherif K, Kushner H, Falkner B: Sex hormone-binding globulin and insulin resistance in African American women. Metabolism 47:70-74, 1998
26. Haffner SM, Katz MS, Stern MP, et al: The relationship of sex hormones to hyperinsulinemia and hyperglycemia. Metabolism 37:683-688, 1988
27. Larsson H, Ahren B: Androgen activity as a risk factor for impaired glucose tolerance in postmenopausal women. Diabetes Care 19:1399-1403, 1996
28. Toscano V, Balducci R, Bianchi R, et al: Steroidal and non-steroidal factors in plasma sex hormone binding globulin regulation. J Steroid Biochem 43:431-437, 1992
29. Maruyama Y, Aoki N, Suzuki Y, et al: Variation with age in the levels of sex steroid-binding plasma protein as determined by radioimmunoassay. Acta Endocrinol (Copenh) 106:428-432, 1984
30. Holly JM, Smith CP, Dunger DB, et al: Relationship between the pubertal fall in sex hormone binding globulin and insulin-like growth factor binding protein-1. A synchronized approach to pubertal development? Clin Endocrinol (Oxf) 31:277-284, 1989
31. Lobo RA: Disturbances in androgen secretion and metabolism in polycystic ovary syndrome. Clin Obstet Gynecol 12:633-647, 1985
32. Botwood N, Hamilton-Fairley D, Kiddy D, et al: Sex hormone-binding globulin and female reproductive function. J Steroid Biochem Mol Biol 53:529-531, 1995
33. Chang RJ, Nakamura RM, Judd HL, et al: Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 57:356-359, 1983
34. Dunaif A, Segal KR, Futterweit W, et al: Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174, 1989
35. Barbieri RL, Makris A, Randall RW, et al: Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab 62:904-910, 1986
36. Nahum R, Thong KJ, Hillier SG: Metabolic regulation of androgen production by human thecal cells in vitro. Hum Reprod 10:75-81, 1995
37. Nestler JE, Barlascini CO, Matt DW, et al: Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 68:1027-1032, 1989
38. Plymate SR, Matej LA, Jones RE: Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 67:460-464, 1988